OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanodermatology‐based solutions for psoriasis: State‐of‐the art and future prospects
Giovanni Damiani, Alessia Pacifico, Dennis Linder, et al.
Dermatologic Therapy (2019) Vol. 32, Iss. 6
Open Access | Times Cited: 28
Giovanni Damiani, Alessia Pacifico, Dennis Linder, et al.
Dermatologic Therapy (2019) Vol. 32, Iss. 6
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Current Concepts of Psoriasis Immunopathogenesis
Marijana Vičić, Marija Kaštelan, Ines Brajac, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11574-11574
Open Access | Times Cited: 105
Marijana Vičić, Marija Kaštelan, Ines Brajac, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11574-11574
Open Access | Times Cited: 105
The Brain–Skin Axis in Psoriasis—Psychological, Psychiatric, Hormonal, and Dermatological Aspects
Luiza Marek‐Józefowicz, Rafał Czajkowski, Alina Borkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 669-669
Open Access | Times Cited: 79
Luiza Marek‐Józefowicz, Rafał Czajkowski, Alina Borkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 669-669
Open Access | Times Cited: 79
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics
Robert G. Petit, Amanda Cano, A. Ortiz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4983-4983
Open Access | Times Cited: 84
Robert G. Petit, Amanda Cano, A. Ortiz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4983-4983
Open Access | Times Cited: 84
Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery
Muhammad Shahid Latif, Asif Nawaz, Mufarreh Asmari, et al.
Gels (2022) Vol. 9, Iss. 1, pp. 3-3
Open Access | Times Cited: 28
Muhammad Shahid Latif, Asif Nawaz, Mufarreh Asmari, et al.
Gels (2022) Vol. 9, Iss. 1, pp. 3-3
Open Access | Times Cited: 28
<p>Cyclodextrin-Modified CeO<sub>2</sub> Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis</p>
Lingyun Wu, Guoyan Liu, Wenyu Wang, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 2515-2527
Open Access | Times Cited: 41
Lingyun Wu, Guoyan Liu, Wenyu Wang, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 2515-2527
Open Access | Times Cited: 41
Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies
Krishna Yadav, Akanksha Soni, Deependra Singh, et al.
Progress in Biomaterials (2021) Vol. 10, Iss. 1, pp. 1-17
Open Access | Times Cited: 36
Krishna Yadav, Akanksha Soni, Deependra Singh, et al.
Progress in Biomaterials (2021) Vol. 10, Iss. 1, pp. 1-17
Open Access | Times Cited: 36
Leaflet Tensions Control the Spatio-Temporal Remodeling of Lipid Bilayers and Nanovesicles
Reinhard Lipowsky, Rikhia Ghosh, Vahid Satarifard, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 926-926
Open Access | Times Cited: 11
Reinhard Lipowsky, Rikhia Ghosh, Vahid Satarifard, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 926-926
Open Access | Times Cited: 11
Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments
Miao Miao, Jiong Yan, Yujin Sun, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2045-2072
Open Access
Miao Miao, Jiong Yan, Yujin Sun, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2045-2072
Open Access
Emerging Therapeutic Agents and Nanotechnology-Driven Innovations in Psoriasis Management
Tarnjot Kaur, Nikita Hinge, Sudeep Pukale, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Tarnjot Kaur, Nikita Hinge, Sudeep Pukale, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis
Prativa Biswasroy, Deepak Pradhan, Biswakanth Kar, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 5
Closed Access | Times Cited: 25
Prativa Biswasroy, Deepak Pradhan, Biswakanth Kar, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 5
Closed Access | Times Cited: 25
Can Essential Oils/Botanical Agents Smart-Nanoformulations Be the Winning Cards against Psoriasis?
Mohamed Ashraf, Hossam S. El‐Sawy, Ghada M. El-Zaafarany, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 750-750
Open Access | Times Cited: 9
Mohamed Ashraf, Hossam S. El‐Sawy, Ghada M. El-Zaafarany, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 750-750
Open Access | Times Cited: 9
Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity
Debarati Maiti, Mohammed Naseeruddin Inamdar, Mansour Almuqbil, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 834-844
Open Access | Times Cited: 9
Debarati Maiti, Mohammed Naseeruddin Inamdar, Mansour Almuqbil, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 834-844
Open Access | Times Cited: 9
Nanodelivery Strategies for Skin Diseases with Barrier Impairment: Focusing on Ceramides and Glucocorticoids
Cíntia Almeida, Patrícia Filipe, Catarina Rosado, et al.
Nanomaterials (2022) Vol. 12, Iss. 2, pp. 275-275
Open Access | Times Cited: 14
Cíntia Almeida, Patrícia Filipe, Catarina Rosado, et al.
Nanomaterials (2022) Vol. 12, Iss. 2, pp. 275-275
Open Access | Times Cited: 14
The Role of Sirtuins in the Pathogenesis of Psoriasis
Sylwia Słuczanowska-Głąbowska, Maria Salmanowicz, Marzena Staniszewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10782-10782
Open Access | Times Cited: 8
Sylwia Słuczanowska-Głąbowska, Maria Salmanowicz, Marzena Staniszewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10782-10782
Open Access | Times Cited: 8
Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
Zih‐Chan Lin, Tsong‐Long Hwang, Tse‐Hung Huang, et al.
Theranostics (2021) Vol. 11, Iss. 10, pp. 4567-4584
Open Access | Times Cited: 15
Zih‐Chan Lin, Tsong‐Long Hwang, Tse‐Hung Huang, et al.
Theranostics (2021) Vol. 11, Iss. 10, pp. 4567-4584
Open Access | Times Cited: 15
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis
Paolo Gisondi, Davide Geat, Patrizio Armeni, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 12, pp. 1579-1584
Closed Access | Times Cited: 10
Paolo Gisondi, Davide Geat, Patrizio Armeni, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 12, pp. 1579-1584
Closed Access | Times Cited: 10
Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies
Jiangmei Xu, Hao Chen, Haisheng Qian, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Jiangmei Xu, Hao Chen, Haisheng Qian, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Novel Herbal Nanocarriers for Treatment of Dermatological Disorders
Dipthi Shree, Chinam Niranjan Patra, Biswa Mohan Sahoo
Pharmaceutical Nanotechnology (2022) Vol. 10, Iss. 4, pp. 246-256
Closed Access | Times Cited: 9
Dipthi Shree, Chinam Niranjan Patra, Biswa Mohan Sahoo
Pharmaceutical Nanotechnology (2022) Vol. 10, Iss. 4, pp. 246-256
Closed Access | Times Cited: 9
Oral Microbiota Variations in Psoriasis Patients Without Comorbidity
Kaidi Zhao, Yang Zhao, Ao Guo, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 2231-2241
Open Access | Times Cited: 1
Kaidi Zhao, Yang Zhao, Ao Guo, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 2231-2241
Open Access | Times Cited: 1
Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
Néboa Zozaya, Renata Villoro, Fernando Abdalla, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00678-adv00678
Open Access | Times Cited: 7
Néboa Zozaya, Renata Villoro, Fernando Abdalla, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00678-adv00678
Open Access | Times Cited: 7
Topical Delivery of Rapamycin by Means of Microenvironment-Sensitive Core-Multi-Shell Nanocarriers: Assessment of Anti-Inflammatory Activity in an ex vivo Skin/T Cell Co-Culture Model
Fiorenza Rancan, Xiao Guo, Keerthana Rajes, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7137-7151
Open Access | Times Cited: 9
Fiorenza Rancan, Xiao Guo, Keerthana Rajes, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7137-7151
Open Access | Times Cited: 9
An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis
Shaheen Parveen, Musheer Ahmed, Sanjula Baboota, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 13, pp. 1082-1102
Closed Access | Times Cited: 6
Shaheen Parveen, Musheer Ahmed, Sanjula Baboota, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 13, pp. 1082-1102
Closed Access | Times Cited: 6
Leukadherin-1 inhibits NLRP3 inflammasome by blocking inflammasome assembly
Yening Zhang, Xiufeng Zhang, Ningjie Zhang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110024-110024
Closed Access | Times Cited: 3
Yening Zhang, Xiufeng Zhang, Ningjie Zhang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110024-110024
Closed Access | Times Cited: 3
How can nanoparticle‐based technologies revolutionize the topical therapy in psoriasis?
Anca Sindrilaru, Gabriela Adriana Filip, Karin Scharffetter‐Kochanek, et al.
Experimental Dermatology (2020) Vol. 29, Iss. 11, pp. 1097-1103
Open Access | Times Cited: 7
Anca Sindrilaru, Gabriela Adriana Filip, Karin Scharffetter‐Kochanek, et al.
Experimental Dermatology (2020) Vol. 29, Iss. 11, pp. 1097-1103
Open Access | Times Cited: 7
Can intermittent, time‐restricted circadian fasting modulate cutaneous severity of dermatological disorders? Insights from a multicenter, observational, prospective study
Nicola Luigi Bragazzi, Khaled Trabelsi, Sergio Garbarino, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 6
Nicola Luigi Bragazzi, Khaled Trabelsi, Sergio Garbarino, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 6
